Diclofenac-induced pseudoporphyria; an under-recognized condition?

Autor:	N. Turnbull, M. Callan, R. C. D. Staughton
Rok vydání:	2014
Předmět:	Adult Male congenital hereditary and neonatal diseases and abnormalities medicine.medical_specialty Diclofenac medicine.medical_treatment Dermatology Porphyrias Psoriatic arthritis chemistry.chemical_compound Humans Medicine Porphyria cutanea tarda skin and connective tissue diseases Dialysis Nonsteroidal business.industry Anti-Inflammatory Agents Non-Steroidal Ultraviolet a medicine.disease Pseudoporphyria stomatognathic diseases chemistry Drug Eruptions business medicine.drug
Zdroj:	Clinical and Experimental Dermatology. 39:348-350
ISSN:	0307-6938
DOI:	10.1111/ced.12313
Popis:	Pseudoporphyria is a photodistributed bullous disorder that is clinically and histologically similar to porphyria cutanea tarda (PCT), but without abnormal porphyrin biochemistry. Renal failure, dialysis, excessive ultraviolet A and medications, particularly nonsteroidal anti-inflammatory drugs (NSAIDs), have been associated with pseudoporphyria. We report a case of diclofenac-induced pseudoporphyria in a man with psoriatic arthritis. To our knowledge, this is only the second reported case of pseudoporphyria associated with diclofenac. Diclofenac has hitherto been considered by many dermatologists as a safe alternative in NSAID-induced pseudoporphyria.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::434afa421b5d07a6a45660e99e962181 https://doi.org/10.1111/ced.12313 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.